Lataa...
Bortezomib a Safe Treatment for Patients with Multiple Myeloma and Cystic Fibrosis
INTRODUCTION: Bortezomib is a proteasome inhibitor that targets myeloma cell and its bone marrow microenvironment. Intravenous Bortezomib with or without dexamethasone, is effective and well tolerated in patients with relapsed/refractory multiple myeloma (MM). METHODS: We used Bortezomib without cor...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Università Cattolica del Sacro Cuore
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3375716/ https://ncbi.nlm.nih.gov/pubmed/22708050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2012.035 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|